For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $15.59 in the prior trading day, Tandem Diabetes Care Inc (NASDAQ: TNDM) closed at $15.75, up 1.03%. In other words, the price has increased by $1.03 from its previous closing price. On the day, 1.66 million shares were traded. TNDM stock price reached its highest trading level at $15.95 during the session, while it also had its lowest trading level at $15.45.
Ratios:
Our goal is to gain a better understanding of TNDM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 2.30. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.78.
On June 16, 2025, Truist started tracking the stock assigning a Hold rating and target price of $24.
On April 10, 2025, Mizuho started tracking the stock assigning a Neutral rating and target price of $20.Mizuho initiated its Neutral rating on April 10, 2025, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Kyrillos Jean-Claude bought 10,538 shares for $18.12 per share. The transaction valued at 190,966 led to the insider holds 10,538 shares of the business.
BLICKENSTAFF KIM D sold 30,000 shares of TNDM for $941,400 on Nov 21 ’24. The Director now owns 165,190 shares after completing the transaction at $31.38 per share. On Nov 20 ’24, another insider, BLICKENSTAFF KIM D, who serves as the Director of the company, sold 10,000 shares for $30.00 each. As a result, the insider received 300,000 and left with 195,190 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNDM now has a Market Capitalization of 1049063424 and an Enterprise Value of 1371035264. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.07 while its Price-to-Book (P/B) ratio in mrq is 6.75. Its current Enterprise Value per Revenue stands at 1.395 whereas that against EBITDA is -18.264.
Stock Price History:
The Beta on a monthly basis for TNDM is 1.49, which has changed by -0.66482234 over the last 52 weeks, in comparison to a change of 0.10611236 over the same period for the S&P500. Over the past 52 weeks, TNDM has reached a high of $48.24, while it has fallen to a 52-week low of $15.17. The 50-Day Moving Average of the stock is -22.28%, while the 200-Day Moving Average is calculated to be -42.88%.
Shares Statistics:
The stock has traded on average 1.59M shares per day over the past 3-months and 2014090 shares per day over the last 10 days, according to various share statistics. A total of 66.57M shares are outstanding, with a floating share count of 65.97M. Insiders hold about 0.96% of the company’s shares, while institutions hold 110.51% stake in the company. Shares short for TNDM as of 1749772800 were 8824052 with a Short Ratio of 6.15, compared to 1747267200 on 7702969. Therefore, it implies a Short% of Shares Outstanding of 8824052 and a Short% of Float of 18.459999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
